We offer a one- or two-year fellowship in neuro-oncology.
Our Neuro-Oncology fellowship offers active participation by fellows in a program that focuses on clinical patient care for primary brain and metastic brain tumors, as well as the effects of cancer treatments and research.
Fellows are directly involved in the management of brain tumor patients in the outpatient clinic at the UAB Kirklin clinic where an average of 10 new patients ( to our practice) and about 60-70 follow-up Brain Tumor patients are seen every week. Fellow will also supervise the inpatient care of Brain Tumor patients admitted to the University of Alabama Hospital. Treatments for patients with malignant brain tumor consist of surgery, conventional chemotherapy and/or radiation. The other line of treatment is experimental treatment with new agents designed to destroy the tumors that cannot be removed by surgery and radiation therapy and to improve the progression free and overall survival and quality of life for the patients.
Clinical and basic and investigations are performed. For clinical investigations, the Neuro-Oncology Program is one of the leading institutional sites for the Adult Brain Tumor Consortium, which is a leading cooperative group supported by the National Cancer Institute. The consortium provides our program access to the latest information and medications, long before they are available to the general medical community. Our program participates with various Industry/Pharmaceutical clinical trials which provide clinical trials with novel/experimental therapies for treatment. The basic investigation interests are in the acquisition and post‐processing of magnetic resonance imaging data in patients with primary brain tumors with a particular interest in the utility of perfusion and diffusion tensor imaging as non‐invasive modalities to evaluate tumor angiogenesis, proliferation, and invasion. Another area of interest is involves the early phase clinical evaluation of novel cancer therapies. This includes the design and implementation of trials for newly diagnosed and recurrent malignant glioma that utilize biologically targeted strategies and includes non‐invasive endpoints in the evaluation of a biological effect.
Other Educational Activities
A multidisciplinary approach to treatment is with neurosurgeons, radiation oncologists, medical oncologists, neuroradiology, and neuro-oncologists providing the best care for patients with uncommon yet complex disorders. The fellow will gain educational training and knowledge when working closing in a multidisciplinary setting which leads to proper care of patients. Fellows are encouraged to interact with other investigators involved in research.
Please send to:
Neuro-Oncology Project Director